In this context, clinicians must be aware that an evaluation of IBD patients, especially those in remission who present with unexplained skin rashes during anti-TNF therapy, should include a skin biopsy and a thorough investigation to exclude organ involvement and other conditions associated with vasculitis, such as infections, non-IBD immune-mediated diseases, and malignancies. This evidence concerns the gene TNF and vasculitis.